retatrutide jay campbell Jay Campbell | Peptides: The

Serious adverse events were similar in incidence between the groups

Tirzepatide 15 mg (Mounjaro/Zepbound) produced 22.5% mean weight loss at 72 weeks in SURMOUNT-1 (N=2,539) [14]

You know you need to do something, but the options are overwhelming

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes

Weight Watchers: Structure and accountability Offers GLP-1 access through WeightWatchers Clinic, layered onto its existing tracking and community framework

Cagrilintide may offer a slightly better tolerability profile with more predictable side effect patterns, though this is based on comparative analysis rather than head-to-head trials